Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H)

Journal of Clinical Pathology

Volumn 67, Issue 6, 2014, Pages 458-463

  Cubie, Heather A ^a   Canham, M ^a   Moore, C ^b   Pedraza, J ^a   Graham, C ^c   Cuschieri, K ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CYTOLOGY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MCNEMAR TEST; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; UTERINE CERVIX CARCINOMA IN SITU;

ASSAY PERFORMANCE;; HPV; CIN; POST-TREATMENT FOLLOW-UP;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; INCIDENCE; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCOTLAND; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84901652697     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-202014     Document Type: Article

References (14)

1. Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30S:F88-99.
2. Kocken M, Helmerhorst TJM, Berkhof J, et al . Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol 2011;12:441-5.
3. Meijer C, Berkhof H, Heideman DAM, et al. Validation of high-risk HPV tests for primary cervical screening. J Clin Virol 2009;S3:S1- 4.
4. Cubie HA, Cuschieri K. Understanding HPV tests and their appropriate applications. Cytopathology 2013.doi:10/1111/cyt.12083. [Epub ahead of print].
5. Szarewski A, Ambroisine L, Cadman L, et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 2008;17:3033-42.
6. Szarewski A, Mesher D, Cadman L, et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol 2012;50:1867-73.
7. Scottish Cervical Screening Programme. Cervical Screening-changes to screening test result categories. http://www.nsd.scot.nhs.uk/services/screening/ cervicalscreening/ (accessed 4 Oct 2013).
8. Sargent A, Bailey A, Turner A, et al. Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol 2010;48:554-8.
9. Arbyn M, Paraskevaidis E, Martin-Hirsche P, et al. Clinical utility of HPV- DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecologic Oncology 2005;99:S7-11.
10. Chan BKS, Melnikow J, Slee CA, et al. Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol 2009;200:422.e1-422.e9.
11. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature. Cancer Treat Rev 2007;33:514 -20.
12. Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2005;118:2048-55.
13. NHS Cancer Screening programmes. HPV triage and test of cure in the cervical screening programme in England. http://www.cancerscreening.nhs.uk/ cervical/hpv-triage-test-of-cure.html (accessed 4 Oct 2013).
14. Legood R, Smith M, Lew J-B, et al. Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neiplasia in england: economic analysis from NHS Sentinel Sites Study. BMJ 2012;345:e7086-96.